Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas

Background: In cancers of prostate, breast, oropharynx, lung, hypopharynx and skin, human tissue kallikreins has been demonstrated as a main role in these problems. There are many research works in which some human tissue kallikreins are expressed in salivary glands. In the present study, the main g...

Full description

Bibliographic Details
Main Authors: Maryam Alsadat Hashemipour, Fatemeh Sadat Fatah, Mohammad Javad Ashraf, Mehrnaz Tahmasebi
Format: Article
Language:English
Published: Iranian Society of Pathology 2016-10-01
Series:Iranian Journal of Pathology
Subjects:
Online Access:https://ijp.iranpath.org/article_22233_606144085c798ff2c1d5f8a511f229c8.pdf
_version_ 1819008875780636672
author Maryam Alsadat Hashemipour
Fatemeh Sadat Fatah
Mohammad Javad Ashraf
Mehrnaz Tahmasebi
author_facet Maryam Alsadat Hashemipour
Fatemeh Sadat Fatah
Mohammad Javad Ashraf
Mehrnaz Tahmasebi
author_sort Maryam Alsadat Hashemipour
collection DOAJ
description Background: In cancers of prostate, breast, oropharynx, lung, hypopharynx and skin, human tissue kallikreins has been demonstrated as a main role in these problems. There are many research works in which some human tissue kallikreins are expressed in salivary glands. In the present study, the main goal was to determine expression of human tissue kallikreins 4, 8, 10, 11 and 13 in pleomorphic adenomas and mucoepidermoid carcinomas. Methods: Sixty-six specimens (45 cases of pleomorphic adenomas and 21 cases mucoepidermoid carcinomas) were selected for final analysis by immunohistochemistry. For doing association test, clinical parameters obtained from the patients’ medical charts, which included age, gender were used and the nonparametric tests employed for statistical analyses. Results: The expression of human kallikreins 4, 8, 11 and 13 was more prominent in benign and malignant tumors compared to that in normal tissues and the difference was significant. In addition, the expression of human kallikreins 4, 8, 10 and 11 in malignant tumors was more than that in benign tumors, with statistically significant differences. Conclusion: The differences in the levels of human kallikreins 4, 8, 11 and 13 suggest that kallikreins may benefit in determining tumor behavior of salivary gland tumors.
first_indexed 2024-12-21T00:47:26Z
format Article
id doaj.art-4c31211f7762480098cfaba03230a83f
institution Directory Open Access Journal
issn 1735-5303
2345-3656
language English
last_indexed 2024-12-21T00:47:26Z
publishDate 2016-10-01
publisher Iranian Society of Pathology
record_format Article
series Iranian Journal of Pathology
spelling doaj.art-4c31211f7762480098cfaba03230a83f2022-12-21T19:21:28ZengIranian Society of PathologyIranian Journal of Pathology1735-53032345-36562016-10-0111433434422233Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid CarcinomasMaryam Alsadat Hashemipour0Fatemeh Sadat Fatah1Mohammad Javad Ashraf2Mehrnaz Tahmasebi3Kerman Dental and Oral Diseases Research Center, Kerman University of Medical Sciences, Kerman, IranDept. of Oral Medicine, School of Dentistry, Shiraz University International Division, Shiraz, IranDept of Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IranKerman Social Determinants on Oral Health Research Center, Kerman University of Medical Sciences, Kerman, IranBackground: In cancers of prostate, breast, oropharynx, lung, hypopharynx and skin, human tissue kallikreins has been demonstrated as a main role in these problems. There are many research works in which some human tissue kallikreins are expressed in salivary glands. In the present study, the main goal was to determine expression of human tissue kallikreins 4, 8, 10, 11 and 13 in pleomorphic adenomas and mucoepidermoid carcinomas. Methods: Sixty-six specimens (45 cases of pleomorphic adenomas and 21 cases mucoepidermoid carcinomas) were selected for final analysis by immunohistochemistry. For doing association test, clinical parameters obtained from the patients’ medical charts, which included age, gender were used and the nonparametric tests employed for statistical analyses. Results: The expression of human kallikreins 4, 8, 11 and 13 was more prominent in benign and malignant tumors compared to that in normal tissues and the difference was significant. In addition, the expression of human kallikreins 4, 8, 10 and 11 in malignant tumors was more than that in benign tumors, with statistically significant differences. Conclusion: The differences in the levels of human kallikreins 4, 8, 11 and 13 suggest that kallikreins may benefit in determining tumor behavior of salivary gland tumors.https://ijp.iranpath.org/article_22233_606144085c798ff2c1d5f8a511f229c8.pdfhuman kallikreinsbenignmalignantsalivary gland tumors
spellingShingle Maryam Alsadat Hashemipour
Fatemeh Sadat Fatah
Mohammad Javad Ashraf
Mehrnaz Tahmasebi
Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
Iranian Journal of Pathology
human kallikreins
benign
malignant
salivary gland tumors
title Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
title_full Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
title_fullStr Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
title_full_unstemmed Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
title_short Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas
title_sort expression of human kallikreins 4 8 10 11 and 13 in pleomorphic adenomas and mucoepidermoid carcinomas
topic human kallikreins
benign
malignant
salivary gland tumors
url https://ijp.iranpath.org/article_22233_606144085c798ff2c1d5f8a511f229c8.pdf
work_keys_str_mv AT maryamalsadathashemipour expressionofhumankallikreins481011and13inpleomorphicadenomasandmucoepidermoidcarcinomas
AT fatemehsadatfatah expressionofhumankallikreins481011and13inpleomorphicadenomasandmucoepidermoidcarcinomas
AT mohammadjavadashraf expressionofhumankallikreins481011and13inpleomorphicadenomasandmucoepidermoidcarcinomas
AT mehrnaztahmasebi expressionofhumankallikreins481011and13inpleomorphicadenomasandmucoepidermoidcarcinomas